Application Information

This drug has been submitted to the FDA under the reference 085248/001.

Names and composition

"TRICHLORMETHIAZIDE W/ RESERPINE" is the commercial name of a drug composed of RESERPINE and TRICHLORMETHIAZIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
085248/001 TRICHLORMETHIAZIDE W/ RESERPINE RESERPINE; TRICHLORMETHIAZIDE TABLET/ORAL 0.1MG and 4MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
012265/003 NAQUIVAL RESERPINE; TRICHLORMETHIAZIDE TABLET/ORAL 0.1MG and 4MG
012972/001 METATENSIN #2 RESERPINE; TRICHLORMETHIAZIDE TABLET/ORAL 0.1MG and 2MG
012972/002 METATENSIN #4 RESERPINE; TRICHLORMETHIAZIDE TABLET/ORAL 0.1MG and 4MG
085248/001 TRICHLORMETHIAZIDE W/ RESERPINE RESERPINE; TRICHLORMETHIAZIDE TABLET/ORAL 0.1MG and 4MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved